Busy week for the ResQ Pharma team: first an important regulatory meeting and today presenting at the Houston Startup Showcase hosted by Portal Innovations, LLC and Polsinelli. We continue to make great strides in brining LipidRescue(tm) to market and save lives. Many thanks to the Portal and Polsinelli teams for hosting this great event. #lipidrescue
About us
ResQ Pharma is a research & development company. Its lead program, LipidRescue Therapy (LRT) is an antidote for various non-opiate drug overdoses and poisonings including all local anesthetics (Lidocaine, Bupivacaine, etc...), benzodiazepines and psychotherapeutics (all antidepres). The FDA recently approved Orphan Drug Designation for LRT's initial sought after indication, local anesthetic systemic toxicity (LAST). ResQ Pharma plans to file applications for market approval for both the USA and EU by the 1st quarter of 2019. In 2015, within the U.S. alone, over 23,000 people died from drug overdoses and poisonings, potentially treatable with LRT.
- Website
-
http://www.Lipidrescue.com
External link for ResQ Pharma, Inc.
- Industry
- Pharmaceutical Manufacturing
- Company size
- 2-10 employees
- Headquarters
- Chicago, Illinois
- Type
- Privately Held
- Founded
- 2015
- Specialties
- Antidotes, Nanomicelles, Lipid Emulsions, Resusitation, critical care, Regional Anesthesia, Advance Cardiovascular Life Support, Life Saving, Global Manufacturing, Commercialization, and Cross over financing
Locations
-
Primary
Get directions
2242 W. Harrison Street
Suite 201
Chicago, Illinois 60612, US
-
Get directions
222 W. Merchandise Mart Plaza
MATTER, Suite #1230
Chicago, Illinois 60654, US
-
Get directions
2242 W Harrison St
Chicago, IL 60612, US
Employees at ResQ Pharma, Inc.
Updates
-
ResQ Pharma, Inc. was back in front of investors at the Chicago Capital Call: Biotech conference hosted today by Cooley LLP. Another great opportunity to showcase the hard work our team has put into bringing #LipidRescue to market in the near future. Thanks to Nader Elrashidy for organizing such a great event to collaborate and network among a diverse and highly-motivated group of people who all share one common goal: saving lives!
-
-
Exciting week for ResQ with opportunities to participate in two conferences. We began in Boston on Wednesday, presenting at the LSX World Congress and meeting with a variety of industry leaders, potential development and operational partners, and investors. On Thursday, we had the pleasure of participating in a panel discussion at the 2FLO Health Equity Investing Symposium, discussing our experiences working with investors and the FDA. Both opportunities allowed us to highlight the importance of #LipidRescue in saving lives. Didn't get a chance to see us at either conference? No problem - reach out anytime to learn more.
-